MAKING THE IMPOSSIBLE
POSSIBLE

News archive

All news

Advanced Therapies awarded ”Vision Driven Health” project

2019-11-26

Vinnova awards 10 million SEK over two years to secure Sweden's ATMP future

Cognate Bioservices aquires Cobra Biologics

2019-11-05

Creates global cell and gene therapy manufacturing services platform

Gene therapy reduces Acute Intermittent Porphyria attacks by 79%

2019-10-21

Promising results from Swedish study published in The New England Journal of Medicine

Register before November 15th for ATMP PhD courses!

2019-10-17

Two great courses covering some ATMP science and the field as a whole

Financing ATMPs – Bedside to Reimbursement

2019-10-16

Part 2 of our September 2019 ATMP financing events in Skåne.

200 million SEK investment in Swedish gene and immunotherapy production

2019-09-23

Cobra Biologics invests 200 million SEK in Matfors facility

Swedish based Ilya Pharma recruiting for first ATMP trial

2019-09-19

Genetically engineered bacteria to drive wound healing

Financing ATMPs – Bench to Bedside

2019-09-16

Part one of our summary of ATMP financing events in Skåne September 2019

Competence centre in NK cell-based immunotherapies to be formed

2019-06-24

A centre for development of the next generation NK cell-based immunotherapies against cancer to be built from Karolinska Institutet.

External ATMP Newsletter Midsummer 2019

2019-06-24

Register for our finance events and AdBIOPRO bioreactor course

Sweden’s first GMP line registered in hPSCreg

2019-06-24

KARO1 is the first GMP hESC line produced at Vecura, there are more to come!

Register for our events in finance and partnering!

2019-06-19

Real examples of taking ATMPs from research to market approval. Who do you need to be partnering with!?

World first, Swedish gene therapy for blindness

2019-06-04

Swedish gene therapy clinical trial for RLBP1 Retinitis Pigmentosa ongoing in Stockholm, Sweden

Better skin for a better life for burns survivors

2019-05-23

Sweden drives National and International collaboration to improve quality of life for burns survivors, saved through skin stem cell transplants

External ATMP Newsletter Spring 2019

2019-05-09

The Conference edition of our Newsletter! Read more about the success that was ATMP Sweden 2019!

Sweden’s Gene and Cell therapy Industry showcased at ATMP Sweden 2019

2019-04-02

The era of gene and cell therapy treatments is here!

New national planning project

2019-03-01

Advanced therapies for future Healthcare

Melanoma gone following treatment with TILs and DC vaccination.

2019-03-01

Good news from of one of our CAMP Projects "Expansion of GMP Compliant Tumor Infiltrating Lymphocytes (TILs) in Xuri bioreactor".

Johan Hyllner Head of Cell and Gene Therapy at AZ.

2019-03-01

We are pleased to hear that Johan Hyllner has been recruited to AstraZeneca as Head of their Cell and Gene Therapy program.

Who is VOG cell and what are they doing now?

2019-02-06

VOG (tissue area Group) cell represents a National network of University hospitals in Sweden.

External ATMP Newsletter Winter 2019

2019-02-06

It's too cold to go outside, browse our newsletter instead!

Cobra focussing on development and manufacture services for ATMPs

2018-11-11

Cobra is currently expanding capacity in both Keele, UK and Matfors, Sweden.

Johan Hyllner on moving back to Sweden

2018-11-11

We caught up with Johan to see what his plans are post Catapult.

New Recruit and new Facility – KI Pre-GMP

2018-11-11

As part of CAMP WP1/WP2 Karolinska Institutet is setting up a pre-GMP core facility.

External ATMP Newsletter Autumn 2018

2018-11-11

Welcome to the first CAMP/Swelife-ATMP quarterly ATMP newsletter!